Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection

• Status: Recruiting
• Trial end date: 2023-03-17
• Target enrollment: 0
• Participant gender: All

Summary

Jinzhen oral liquid and Jinhuaqinggan Granules were used in the treatment and the control group for 14 days, respectively, to evaluate the effect of Jinzhen oral liquid in treating children with novel coronavirus infection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Affiliated Hospital of Qingdao University

Criteria

Inclusion Criteria:

• 1. Meet the diagnostic criteria of novel coronavirus infected patients in COVID-19 Diagnosis and Treatment Protocol (Trial Version 9);

2. Asymptomatic infection or clinical classification of mild or common type;

3. Aged from 3 to 18 years;

4. The informed consent process was in accordance with the regulations, and the legal guardian or the children (≥8 years old) signed the informed consent form.

Exclusion Criteria:

• 1. Meet the severe/critical early warning indicators;

2. Children who used proprietary Chinese medicine of the same type for more than 3 days before enrollment;

3. Children with diarrhea.